This is a routine annual meeting with no material changes. Monitor for any unexpected shareholder proposals or voting outcomes, but no immediate trading implications.
STRO drugs
STRO drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 23 $34.83entry
- T+1 · 7mo ago −4.31%α −5.09% · $33.33
- T+5 · 7mo ago +1.61%α +0.13% · $35.39
- T+20 · 6mo ago −10.62%α −15.26% · $31.13
- T+60 · 4mo ago −35.14%α −40.16% · $22.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Sutro Biopharma is holding its annual shareholder meeting to elect directors, ratify auditors, and approve executive compensation. This is a routine corporate governance filing with no material financial or strategic changes.
Key Financial Metrics
Key Facts
- Sutro Biopharma is holding its annual shareholder meeting on June 5, 2026
- Shareholders will vote on the election of Class II directors (Jane Chung, Connie Matsui, James Panek)
- Shareholders will vote to ratify Ernst & Young LLP as the independent auditor
- Shareholders will vote on a non-binding advisory vote on executive compensation
Financial Impact
No material financial impact from this filing
Risk Factors
- None identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-170441 |
| Document: 0001193125-26-170441-index-headers.html | 0001193125-26-170441 |
| Document: 0001193125-26-170441-index.html | 0001193125-26-170441 |
| Document: 0001193125-26-170441.txt | 0001193125-26-170441 |
Track record
8 reports on STRO
2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +50.74% at T+20 after the Mar 23, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Bearish 5/10 Entry $9.82 to $9.32 Now $9.32 +5.09% ▲ +5.09% +3.18% vs SPY
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $10.61 to $10.17 Now $9.32 −12.16% ▼ −4.15% −3.78% vs SPY
- Aug 12, 202613w ago 8-K Bullish 7/10 No price data
- Aug 12, 202613w ago Press Release Mixed 6/10 Entry $21.30 to $21.31 Now $9.32 −56.24% ▲ +0.05% −0.65% vs SPY
- Apr 22, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $34.83 to $33.33 Now $9.32 −73.24% ▼ −4.31% −5.09% vs SPY
- Apr 19, 202630w ago Press Release Bullish 7/10 Entry $34.58 to $34.35 Now $9.32 −73.05% ▼ −0.67% −0.01% vs SPY
- Mar 23, 202634w ago S-3 Bearish 6/10 Entry $23.57 to $23.50 Now $9.32 +60.46% ▲ +0.30% +0.86% vs SPY
- Mar 23, 202634w ago Press Release Bullish 7/10 Entry $23.57 to $23.50 Now $9.32 −60.46% ▼ −0.30% −0.86% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers